A cross-sectional relationship between vital capacity and diabetes in Japanese men

Diabetes Research and Clinical Practice

Volumn 85, Issue 1, 2009, Pages 111-116

  Oda, Eiji ^a   Kawai, Ryu ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

Adipose tissue disease; C reactive protein; Diabetes; Metabolic syndrome; Vital capacity

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; GLUCOSE;

ADULT; ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; DIET RESTRICTION; DISEASE MARKER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; JAPANESE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; HEART RATE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; VITAL CAPACITY;

EID: 67349284075     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.04.011     Document Type: Article

References (23)

1. Alverti K.G.M.M., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23 (2006) 469-480
2. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
3. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
4. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens. Res. 31 (2008) 1285-1293
5. Tozawa M., Iseki C., Tokashiki K., Chinen S., Kohagura K., Kinjo K., et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens. Res. 31 (2007) 937-943
6. Kawamoto R., Kohara K., Tabara Y., and Miki T. An association between metabolic syndrome and the estimated glomerular filtration rate. Intern. Med. 47 (2008) 1399-1406
7. Fabbri L.M., and Rabe K.F. From COPD to chronic systemic inflammatory syndrome?. Lancet 370 (2007) 797-799
8. Kotronen A., and Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thrommb. Vasc. Biol. 28 (2008) 27-38
9. Lazarus R., Sparrow D., and Weiss S.T. Baseline ventilator function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur. Respir. J. 12 (1998) 641-645
10. Engstrom G., and Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet. Med. 19 (2002) 167-170
11. Engstrom G., Hedblad B., Nilsson P., Wollmer P., Berglund G., and Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J. Intern. Med. 253 (2003) 574-581
12. Ford E.S., and Mannino D.M. Prospective association between lung function and the incidence of diabetes. Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 27 (2004) 2966-2970
13. Yeh H., Punjabi N.M., Wang N., Pankow J.S., Duncan B.B., and Brancati F.L. Vital capacity as a predictor of incident type 2 diabetes. The Atherosclerosis Risk in Communities Study. Diabetes Care 28 (2005) 1472-1479
14. Nakajima K., Kubouchi Y., Muneyuki T., Ebata M., Eguchi S., and Munakata H. A possible association between suspected restrictive patter as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 134 (2008) 712-718
15. Sakuta H., Suzuki T., Yasuda H., and Ito T. Vital capacity and selected metabolic diseases in middle-aged Japanese men. Can. Respir. J. 13 (2006) 79-82
16. The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome. J. Jpn. Soc. Intern. Med. 94 (2005) 794-809 (in Japanese)
17. Sattar N., McConnachie A., Shaper G., Blauw G., Buckley B.M., de Craen A.J., et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371 (2008) 1927-1935
18. Brantsma A.H., Bakker S.J.L., Hillege H.L., de Zeeuw D., de Jong P.E., and Gansevoort RT the PREVEND Study Group. Urinary albumin excretion and its relation with C-reactive protein and metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28 (2005) 2525-2530
19. Chance W.W., Rhee C., Yilmaz C., Dane D.M., Pruneda M.L., Raskin P., et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 31 (2008) 1596-1601
20. Oda E., and kawai R. A tentative cut point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese. Circ. J. 73 (2009) 755-759
21. Fimognari F.L., Pasqualetti P., Moro L., Franco A., Piccirillo G., Pastorelli R., et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J. Gerontol. 62 (2007) 760-765
22. Lazarus R., Sparrow D., and Weiss S.T. Hand-grip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study. Metabolism 46 (1997) 1266-1269
23. Fernandez-Real J.M., Chico B., Shiratori M., Nara Y., Takahashi H., and Ricart W. Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care 31 (2008) 958-963